Scotts Miracle-Gro (SMG) presents a potential investment opportunity as it plans to sell its unprofitable cannabis subsidiary, Hawthorne Gardening, by the end of the year. This sale could be a positive catalyst for SMG's stock, removing a major source of financial losses and allowing a refocus on its stable core business. The broader cannabis industry remains a highly speculative investment due to its federal status as a Schedule 1 drug, which severely impacts profitability. A key near-term catalyst to watch for is the potential rescheduling of cannabis to Schedule 3, which would be a significant positive step for the entire sector. Investors should monitor SMG for the completion of the Hawthorne sale and the cannabis sector for any news on federal rescheduling.

Scotts Miracle-Gro (SMG)

• Core Business: A dominant player in the lawn and garden industry, with products like potting soil found in major retailers like Lowe's, Home Depot, and Walmart.
• Entry into Cannabis: Faced with stalling growth after the 2008 recession, CEO Jim Hagedorn saw an opportunity in the growing cannabis market.
  • To avoid the risks of federal illegality, the company did not grow or sell cannabis directly.
  • Instead, it created a subsidiary called The Hawthorne Gardening Company to act as a "picks and shovels" supplier to the industry.
  • Hawthorne acquired established hydroponics companies like General Hydroponics and Vermicrop to sell equipment, soil, lights, and filtration systems to cannabis growers.
• Pandemic Boom: The company's stock price more than doubled during the pandemic.
  • Cannabis consumption reached new heights, and Hawthorne's business boomed.
  • Investors viewed SMG as a safer way to get exposure to the cannabis industry without directly investing in federally illegal operations.
• Post-Pandemic Bust: As the pandemic receded, cannabis demand fell, leading to an oversupply in the market and a collapse in wholesale cannabis prices.
  • Hawthorne's customers (the growers) began to struggle, fold, or cut back on purchasing supplies.
  • This caused Hawthorne's revenue to slump and turn into "pretty major losses," which negatively impacted the overall bottom line of Scotts Miracle-Gro.
• Current Strategy: The company has been "burned by this whole experience" and is now looking to sell the Hawthorne Gardening subsidiary by the end of the year.
  • However, they are not completely abandoning the idea. They are reportedly looking to structure a deal that would allow them to buy Hawthorne back in the future if cannabis is legalized at the federal level.

Takeaways

• SMG is a story of two distinct businesses: a stable, traditional lawn and garden company and a high-risk, high-volatility cannabis supply venture.
• The investment thesis for SMG as a cannabis play has soured significantly. The Hawthorne subsidiary has become a major financial drag on the parent company.
• The planned sale of Hawthorne could be a positive catalyst for SMG's stock, as it would remove a source of significant losses and allow the company to refocus on its profitable core business.
• The option to buy Hawthorne back represents a long-term, low-risk call option on federal cannabis legalization for the company, but it is not a reason to invest today.

The Cannabis Industry (Investment Theme)

• Industry Trajectory: The legal cannabis industry grew rapidly in the 2010s due to state-by-state legalization. It experienced a massive boom during the pandemic, but this led to an "overbuild."
• Current State: The industry has "run into a wall."
  • There is too much supply, which has caused the wholesale price of cannabis to collapse.
  • Many cannabis cultivation companies are struggling financially, folding, or slashing staff.
• Primary Headwind: The biggest obstacle for the entire industry is that marijuana remains a Schedule 1 drug under U.S. federal law, in the same category as heroin.
  • This status means cannabis businesses cannot deduct ordinary business expenses from their taxes, making it "extremely hard to turn a profit."
  • It also limits access to traditional banking and financing.
• Potential Catalysts: The future success of the industry is highly dependent on changes in federal law.
  • Full Federal Legalization: This is the ultimate goal for the industry and would be like "the gates opening," allowing companies to operate like normal businesses and unlocking legitimacy.
  • Rescheduling: A more near-term possibility is the rescheduling of cannabis from Schedule 1 to a less restrictive category like Schedule 3. This would be a significant positive step, though not full legalization. The podcast notes that the Trump administration had expressed interest in this, with a decision expected "in a few weeks" from the time of the discussion.

Takeaways

• Investing in the cannabis industry is currently a highly speculative bet on U.S. federal policy changes.
• The story of Hawthorne serves as a "moral tale" that even "picks and shovels" plays (investing in suppliers) are not safe when the underlying industry faces fundamental profitability challenges due to regulation.
• The key risk is the lack of profitability due to federal tax laws (Schedule 1 status). The key catalyst to watch for is any movement on rescheduling or full legalization.
• The transcript suggests a powerful lesson for investors: "being early can sometimes be just as bad as being wrong." The industry needs federal law to catch up before it can become a stable, investable sector.